122 related articles for article (PubMed ID: 37924867)
1. Non-linear associations of circulating total bilirubin concentration with the risk of nonalcoholic fatty liver disease and all-cause mortality.
Han H; Yu Q; Qin N; Song B; Meng Y; Feng Z; Li Z; Chen L
Ann Hepatol; 2024; 29(2):101177. PubMed ID: 37924867
[TBL] [Abstract][Full Text] [Related]
2. Association of serum uric acid with all-cause and cardiovascular mortality among adults with nonalcoholic fatty liver disease.
Yang S; Ye Z; Liu M; Zhang Y; Wu Q; Zhou C; Zhang Z; He P; Zhang Y; Li H; Liu C; Qin X
Clin Endocrinol (Oxf); 2023 Jan; 98(1):49-58. PubMed ID: 35968564
[TBL] [Abstract][Full Text] [Related]
3. Association Between Secondhand Smoke Exposure and Nonalcoholic Fatty Liver Disease in the General U.S. Adult Nonsmoker Population.
Liu E; Li Q; Pan T; Chen Y
Nicotine Tob Res; 2024 May; 26(6):663-668. PubMed ID: 38124389
[TBL] [Abstract][Full Text] [Related]
4. Association between nonalcoholic fatty liver disease and erectile dysfunction among American Adults from the National Health and Nutrition Examination Survey: a cross-sectional study.
Youcheng L; Xun W; Zhufeng C
Int J Impot Res; 2024 May; ():. PubMed ID: 38783042
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease, circulating ketone bodies and all-cause mortality in a general population-based cohort.
Post A; Garcia E; van den Berg EH; Flores-Guerrero JL; Gruppen EG; Groothof D; Westenbrink BD; Connelly MA; Bakker SJL; Dullaart RPF
Eur J Clin Invest; 2021 Dec; 51(12):e13627. PubMed ID: 34120339
[TBL] [Abstract][Full Text] [Related]
6. The systemic immune-inflammation index was non-linear associated with all-cause mortality in individuals with nonalcoholic fatty liver disease.
Zhao E; Cheng Y; Yu C; Li H; Fan X
Ann Med; 2023 Dec; 55(1):2197652. PubMed ID: 37052341
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the association between urinary glyphosate exposure and fatty liver index: a study for US adults.
Han K; Gao L; Xu H; Li J; Han L; Shen J; Sun W; Gao Y
BMC Public Health; 2024 Mar; 24(1):703. PubMed ID: 38443890
[TBL] [Abstract][Full Text] [Related]
8. Selenium intake in relation to all-cause and cardiovascular mortality in individuals with nonalcoholic fatty liver disease: A nationwide study in nutrition.
Dong X; Deng Y; Chen G
PLoS One; 2024; 19(5):e0303140. PubMed ID: 38768120
[TBL] [Abstract][Full Text] [Related]
9. Total Bilirubin Levels in Nonalcoholic Fatty Liver Disease and All- cause and Cause-specific Mortality in US Adults.
Moss K; Dennis BB; Naji L; Ahmed A; Kim D
J Gastrointestin Liver Dis; 2023 Sep; 32(3):323-331. PubMed ID: 37774224
[TBL] [Abstract][Full Text] [Related]
10. L-shaped association between the GA/HbA1c ratio and all-cause mortality in U.S. adults with NAFLD: a cross-sectional study from the NHANES 1999-2004.
Zhang Z; Wang H; Chen M; Chen Y
BMC Endocr Disord; 2024 Mar; 24(1):35. PubMed ID: 38468235
[TBL] [Abstract][Full Text] [Related]
11. Oral Diseases Associated with Nonalcoholic Fatty Liver Disease in the United States.
Weintraub JA; Lopez Mitnik G; Dye BA
J Dent Res; 2019 Oct; 98(11):1219-1226. PubMed ID: 31369716
[TBL] [Abstract][Full Text] [Related]
12. The Association between Non-Alcoholic Fatty Liver Disease (NAFLD) and Advanced Fibrosis with Serological Vitamin B12 Markers: Results from the NHANES 1999-2004.
Li L; Huang Q; Yang L; Zhang R; Gao L; Han X; Ji L; Zou X
Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334881
[TBL] [Abstract][Full Text] [Related]
13. Circulating total bilirubin and risk of non-alcoholic fatty liver disease in the PREVEND study: observational findings and a Mendelian randomization study.
Kunutsor SK; Frysz M; Verweij N; Kieneker LM; Bakker SJL; Dullaart RPF
Eur J Epidemiol; 2020 Feb; 35(2):123-137. PubMed ID: 31773475
[TBL] [Abstract][Full Text] [Related]
14. The Repeatedly Elevated Fatty Liver Index Is Associated With Increased Mortality: A Population-Based Cohort Study.
Lee CH; Han KD; Kim DH; Kwak MS
Front Endocrinol (Lausanne); 2021; 12():638615. PubMed ID: 33776934
[TBL] [Abstract][Full Text] [Related]
15. Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease.
Golabi P; Gerber L; Paik JM; Deshpande R; de Avila L; Younossi ZM
JHEP Rep; 2020 Dec; 2(6):100171. PubMed ID: 32964202
[TBL] [Abstract][Full Text] [Related]
16. Validation and Comparison of Two Dietary Indexes for Predicting Nonalcoholic Fatty Liver Disease in US Adults.
Li R; Chen Z
J Nutr; 2023 Jan; 152(12):2865-2876. PubMed ID: 36190320
[TBL] [Abstract][Full Text] [Related]
17. Depression is associated with non-alcoholic fatty liver disease among adults in the United States.
Kim D; Yoo ER; Li AA; Tighe SP; Cholankeril G; Harrison SA; Ahmed A
Aliment Pharmacol Ther; 2019 Sep; 50(5):590-598. PubMed ID: 31328300
[TBL] [Abstract][Full Text] [Related]
18. Independent associations of serum calcium with or without albumin adjustment and serum phosphorus with nonalcoholic fatty liver disease: results from NHANES 1999-2018.
Qi H; Wang B; Zhu L
Front Endocrinol (Lausanne); 2024; 15():1323990. PubMed ID: 38505748
[TBL] [Abstract][Full Text] [Related]
19. Copper exposure association with prevalence of non-alcoholic fatty liver disease and insulin resistance among US adults (NHANES 2011-2014).
Chen C; Zhou Q; Yang R; Wu Z; Yuan H; Zhang N; Zhi M; Zhang Y; Ni X; Wang Z; Gao D; Zhu X; Cai J; Yang Z; Sun L
Ecotoxicol Environ Saf; 2021 May; 218():112295. PubMed ID: 33962276
[TBL] [Abstract][Full Text] [Related]
20. Elevated urinary bisphenol A levels are associated with non-alcoholic fatty liver disease among adults in the United States.
Kim D; Yoo ER; Li AA; Cholankeril G; Tighe SP; Kim W; Harrison SA; Ahmed A
Liver Int; 2019 Jul; 39(7):1335-1342. PubMed ID: 30924602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
